'Europe was not left': the United States bought the world stock of remdesivir for the treatment of COVID-19
The United States has purchased almost the entire world stock of remdesivir, an antiviral drug that can accelerate the recovery of patients infected with coronavirus, writes New York Post.
Head of the Department of Health and Human Services (HHS) Alex Hazard announced an agreement to provide a large amount of medicine from Gilead Sciences until September, which will allow American hospitals to buy it.
“President Trump has struck an amazing deal to give Americans access to the first authorized drug for the treatment of COVID-19,” Azar said in a statement. “Whenever possible, we want any American patient who needs remdesivir to get it. The Trump administration is doing everything it can to learn more about life-saving drugs for COVID-19 and to ensure that these options are available to the American people. "
The head of the HHS said more than 500 treatments were booked for Americans.
“This represents 100 percent of Gilead's projected July production (94 treatments), 200 percent of August production (90 treatments), and 174,900 percent of September production (90 treatments), in addition to the appropriation for clinical trials,” said he.
Remdesivir will cost $ 3120 for a typical patient with private health insurance, or it will cost hospitals about $ 520 per dose for one patient with private insurance.
According to the Wall Street Journal, a shorter, more common course of treatment will cost $ 3120, and a longer course, $ 5720.
According to Euronews, this antiviral drug is the only one approved by the European Medicines Agency for the treatment of patients with coronavirus.
Another drug that has been shown to have an effect in coronavirus patients is the steroid dexamethasone, which has been shown to reduce deaths in the most severely ill patients.
“They have access to most of the [remdesivir] drugs, so there’s nothing left for Europe,” Dr. Andrew Hill, a senior visiting fellow at the University of Liverpool, told the British Guardian.
“This is the first major drug approved, and where is the access mechanism? We're at the end of the line again, ”he said.
Hill added that the UK can still obtain remdesivir through a so-called compulsory license, which revokes the company's intellectual property rights.
This would allow the purchase of medicine from generic companies in Bangladesh or India, where the Gilead patent is not recognized, according to the Guardian.
stdClass Object ([term_id] => 12 [name] => In the US [taxonomy] => category [slug] => novosti-ssha)In the U.S.
stdClass Object ([term_id] => 28340 [name] => coronavirus [taxonomy] => post_tag [slug] => koronavirus)coronavirus
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
stdClass Object ([term_id] => 28353 [name] => READ ABOUT CORONAVIRUS [taxonomy] => special [slug] => kitajskij-koronavirus)
stdClass Object ([term_id] => 28455 [name] => COVID-19 [taxonomy] => post_tag [slug] => covid-19)COVID-19
stdClass Object ([term_id] => 28575 [name] => coronavirus treatment [taxonomy] => post_tag [slug] => lechenie-koronavirusa)coronavirus treatment
Read also on ForumDaily:
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.